Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-GUANFACINE XR | 2MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-08 | 2024-01-12 | 212949 |
| APO-GUANFACINE XR | 4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-15 | 2024-01-12 | 213559 |
| APO-GUANFACINE XR | 3MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-22 | 2024-01-12 | 214220 |
| APO-GUANFACINE XR | 2MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-12-22 | 2024-01-12 | 214232 |
| APO-GUANFACINE XR | 1MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-10-06 | 2024-01-12 | 206579 |
| APO-GUANFACINE XR | 1MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-06 | 2024-01-12 | 209339 |
| APO-HALOPERIDOL TAB 10MG | 10MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18945 |
| APO-HYDRALAZINE | 25MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18184 |
| APO-HYDRALAZINE | 50MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18187 |
| APO-HYDRALAZINE | 10MG | TABLET | Resolved | 2017-08-03 | 2017-10-10 | 18190 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2022-10-28 | 2023-01-06 | 172882 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2022-11-11 | 2022-12-23 | 174332 |
| APO-HYDRALAZINE | 10MG | TABLET TABLET | Resolved | 2022-11-27 | 2022-12-23 | 175889 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2025-01-09 | 2025-02-07 | 247379 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-05-24 | 2024-06-14 | 228804 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-06-27 | 2024-09-20 | 231481 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2021-05-25 | 2021-07-15 | 139842 |
| APO-HYDRALAZINE | 50MG | TABLET TABLET | Resolved | 2021-06-18 | 2021-07-15 | 141238 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2023-09-22 | 2023-11-06 | 204999 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-01-19 | 2024-04-05 | 216650 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI CAP 250MG | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
| APO-AMOXI CAP 500MG | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4906 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
| APO-AMOXI SUGAR FREE | 250MG | POWDER FOR SUSPENSION | Discontinued | 2020-06-22 | 2020-06-22 | 118526 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |
| APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60261 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60267 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
| APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
| APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
| APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |